EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitHistorischer BeitragOpen access · CC BY-NC 4.0

Botulinum Neurotoxins: History, Mechanism, and Applications. A Narrative Review

Arik Monash, Joseph Tam, Osnat Rosen, Hermona Soreq iD

Journal of Neurochemistry · 2025-08 · 169 (8)

DOI: 10.1111/jnc.70187 ↗

At a glance

Übersichtsarbeit in Journal of Neurochemistry, published online on 2025-08-05. Written by Arik Monash and 3 co-authors. Institution: Department of Biotechnology, Israel Institute for Biological Research (IIBR), Ness Ziona, Israel. Major MEDLINE topics: Botulinum Toxins, Neurotoxins. Cited 21 times so far (Crossref); 130 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Israel Science Foundation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Botulinum neurotoxins (BoNTs), produced by Clostridium botulinum , exert their potent neuroparalytic effects by specifically targeting presynaptic cholinergic nerve terminals. BoNTs consist of a heavy chain that mediates high‐affinity neuronal binding and endocytosis, and a light chain that, once translocated into the cytosol, acts as a zinc‐dependent metalloprotease. The light chain cleaves SNARE proteins essential for synaptic vesicle fusion, thereby inhibiting acetylcholine release and leading to flaccid paralysis. This intoxication spans foodborne, wound, and infant botulism, all characterized by commonly observed heat‐resistant endospores that enable bacterial survival under adverse conditions. BoNT intoxication induces flaccid paralysis, and both natural and synthetic neurotoxins disrupt neuronal communication by targeting synaptic components. However, BoNTs differ in their origin, mechanism of action, structure, and interactions. Clinical harnessing of non‐poisoning low doses of BoNT/A and BoNT/B serotypes is used for alleviating symptoms of diverse diseases. Molecular engineering and clinical formulation enabled BoNTs optimization into pharmacologically safe and targeted therapeutic agents that replicate the selective neuronal silencing observed in their natural forms. image

Subjects

MeSH terms (MEDLINE)

Botulinum ToxinsNeurotoxinsHumansAnimalsBotulismHistory, 20th CenturyClostridium botulinum

Author keywords

SNARE proteinsacetylcholinebotulinumneuromuscular junctionsneurotransmitter releasetoxin

Substances

Botulinum ToxinsNeurotoxins

Authors and institutions

  • Department of Biotechnology, Israel Institute for Biological Research (IIBR), Ness Ziona, Israel.
  • Obesity and Metabolism Laboratory, Faculty of Medicine, Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Department of Infectious Diseases, IIBR, Ness Ziona, Israel.
  • The Edmond and Lily Safra Center for Brain Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.

ORCID profiles: Hermona Soreq

Funding

  • Israel Science Foundation

Cite

APA

Monash, A., Tam, J., Rosen, O., & Soreq, H. (2025). Botulinum Neurotoxins: History, Mechanism, and Applications. A Narrative Review. Journal of Neurochemistry, 169(8). https://doi.org/10.1111/jnc.70187

Vancouver

Monash A, Tam J, Rosen O, Soreq H. Botulinum Neurotoxins: History, Mechanism, and Applications. A Narrative Review. Journal of Neurochemistry. 2025;169(8). doi:10.1111/jnc.70187

BibTeX
@article{Monash2025,
  author = {Monash, Arik and Tam, Joseph and Rosen, Osnat and Soreq, Hermona},
  title = {Botulinum Neurotoxins: History, Mechanism, and Applications. A Narrative Review},
  journal = {Journal of Neurochemistry},
  year = {2025},
  volume = {169},
  number = {8},
  doi = {10.1111/jnc.70187}
}
Start for free →